Supplementary_materials – Supplemental material for Combination therapy of gefitinib and miR-30a-5p may overcome acquired drug resistance through regulating the PI3K/AKT pathway in non-small cell lung cancer

Fengfeng Wang, Fei Meng, Sze Chuen Cesar Wong, William C.S. Cho, Sijun Yang, Lawrence W.C. Chan
2020 Figshare  
Supplemental material, Supplementary_materials for Combination therapy of gefitinib and miR-30a-5p may overcome acquired drug resistance through regulating the PI3K/AKT pathway in non-small cell lung cancer by Fengfeng Wang, Fei Meng, Sze Chuen Cesar Wong, William C.S. Cho, Sijun Yang and Lawrence W.C. Chan in Therapeutic Advances in Respiratory Disease
doi:10.25384/sage.12514445.v1 fatcat:plvxyf27aba4zedqpmly7go32m